Investigating the effect of the combination of a cardiovascular drug and an anesthetic drug on the amount of bleeding during nose surgery

Phase 3

Recruiting

• Conditions: The amount of bleeding during rhinoplasty surgery.; Follow-up care involving plastic surgery of head and neck; Z42.0

• Registration Number: IRCT20221202056688N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Rhinoplasty surgery candidate
No history of nose surgery
Not suffering from chronic and severe diseases (diabetes, high blood pressure, cancer, etc.)
patients with physical class higher than 2

Exclusion Criteria

Patients with systolic blood pressure less than 100 mm Hg
Heart rate less than 60 per minute
Patients with relative or absolute prohibition of general anesthesia
Patients with chronic drug or alcohol use
Specific use of any interfering drug during anesthesia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding volume. Timepoint: After the operation is completed. Method of measurement: Calculating the amount of blood in the suction, sterile gases and the surgeon's satisfaction with the surgical field.;Blood pressure. Timepoint: Before the operation, 15-30-45 minutes after the start of the intervention and the end of the operation. Method of measurement: By monitoring the patient's vital signs.;Heart rate. Timepoint: Before the operation, 15-30-45 minutes after the start of the intervention and the end of the operation. Method of measurement: By monitoring the patient's vital signs.